MAYNE PHARMA GROUP LIMITED

2.17%

$4.50

Market Cap $365.6M

Healthcare Drug Manufacturers - Specialty & Generic

Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused... Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company focused on commercializing novel pharmaceuticals. The Company also provides contract development and manufacturing services to clients worldwide. The Company’s segments include Women’s Health, Dermatology, and International. The Women’s Health segment distributes women’s health branded products in the United States. This segment includes NEXTSTELLIS, ANNOVERA, BIJUVA, IMVEXXY and branded pre-natal vitamins. The Dermatology segment distributes established dermatology products in the United States. The International segment is engaged in the manufacture and sale of branded and generic pharmaceutical products globally and the provision of contract development and manufacturing services to third party customers. The Company's products include ACTIKERALL Solution, ASTRIX Capsules and Tablets, MAGNOPLASM Paste and SPLINTEX Splinter Removal Gel, and ANNOVERA Vaginal Ring, among others.More

Neurizon's (ASX:NUZ) NUZ-001 OLE Study Demonstrates Long-Term Safety and Efficacy Signals

Latest Threads

Tag

Subject

MYX

Ann: Mayne Pharma addresses recent media articles regarding FIRB

10/09/25

14K

10/09/25

Last post formuso

14K

MYX

Nextstellis

10/09/25

540

10/09/25

Last post Hiddenvalue

540

MYX

Cosette Case Weak

08/09/25

31K

08/09/25

Last post daicosisgod

31K

MYX

AFR on FIRB intervention

08/09/25

1.3K

08/09/25

Last post newB

1.3K

MYX

AFR on ASIC and Mayne

05/09/25

2.6K

05/09/25

Last post Bearwolf

2.6K

MYX

Ann: 2025 Full Year Results Investor Presentation

29/08/25

5.9K

29/08/25

Last post Dabble010

5.9K

MYX

Ann: Notification of cessation of securities - MYX

29/08/25

196

29/08/25

Last post

ASX News

196

MYX

Ann: 2025 Full Year Results Media Release

29/08/25

238

29/08/25

Last post

ASX News

238

See All Discussions

Timeline

Mayne Pharma addresses recent media articles regarding FIRB
08 Sep 09:02	Share

Notification of cessation of securities - MYX
29 Aug 16:49	Share

2025 Full Year Results Investor Presentation
29 Aug 09:19	Share

2025 Full Year Results Media Release
29 Aug 09:19	Share

Full Year Statutory Accounts
29 Aug 09:18	Share

Change in substantial holding
15 Aug 16:51	Share

Becoming a substantial holder from MUFG
14 Aug 17:45	Share

Becoming a substantial holder
13 Aug 16:43	Share

Change in substantial holding
06 Aug 18:17	Share

Additional notice of intention to terminate from Cosette
05 Aug 19:24	Share

Ceasing to be a substantial holder from MUFG
02 Jul 17:53	Share

Ceasing to be a substantial holder
01 Jul 15:57	Share

Becoming a substantial holder from MUFG
27 Jun 17:18	Share

Becoming a substantial holder
26 Jun 18:02	Share

Ceasing to be a substantial holder
25 Jun 08:21	Share

Change in substantial holding
24 Jun 17:55	Share

Ceasing to be a substantial holder from MUFG
20 Jun 16:40	Share

Ceasing to be a substantial holder
19 Jun 17:54	Share

Results of Scheme Meeting
18 Jun 11:22	Share

Chair's address and presentation at the Scheme Meeting
18 Jun 09:13	Share

Change in substantial holding from MUFG
17 Jun 17:54	Share

Ceasing to be a substantial holder from MS
17 Jun 16:02	Share

Update on litigation with Cosette
16 Jun 08:49	Share

MYX receives further purported notice to terminate SID
13 Jun 15:20	Share

Change in substantial holding
11 Jun 18:40	Share

Change in substantial holding from MUFG
11 Jun 17:49	Share

Becoming a substantial holder from MS
11 Jun 08:19	Share

Change in substantial holding
10 Jun 18:05	Share

Change in substantial holding
10 Jun 17:35	Share

Change in substantial holding
10 Jun 17:27	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.50		Change -0.100(2.17%)		Mkt cap ! $365.6M

Open	High	Low	Value	Volume
$4.60	$4.61	$4.49	$1.425M	314.8K

Buyers (Bids)

No.	Vol.	Price($)
1	1516	$4.50

Sellers (Offers)

Price($)	Vol.	No.
$4.54	47	1

View Market Depth

No.	Vol.	Price($)
1	1516	4.500
1	6000	4.490
1	5000	4.470
2	2300	4.460
4	5814	4.450

Price($)	Vol.	No.
4.540	47	1
4.550	2000	1
4.570	479	1
4.620	1828	1
4.640	1829	1

Last trade - 16.11pm 10/09/2025 (20 minute delay)

MYX (ASX) Chart

MAYNE PHARMA GROUP LIMITED

Latest Threads

LU7 and Macquarie apply for AEA Grant to transform solar recycling

Timeline

Featured News

Latest Articles

Mayne Pharma nosedive deepens as Cosette mulls scrapping $672M buy-up

Mayne Pharma Group (ASX:MYX) has been taking a beating in the markets this week, with company value as much as -33% lower @ today down to $4.34 a share after opening Week 21 at $6.48 @ on second thoughts from Cosette.Listen to the HotCopper podcast for in-depth discussions and insights on all the...

Mayne Pharma to pay A$33M in class action settlement on alleged US conduct

Mayne Pharma (ASX:MYX) has announced it will pay A$38M – $4.7M covered by insurance – to settle a class action brought in 2021.

Mayne Pharma Group (ASX:MYX) announces on-market buyback program

Mayne Pharma (ASX:MYX) has announced an on-market share buyback program for up to 10 per cent of the company's issued capital.

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News